BioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum<blockquote>BioNTech从吉利德手中收购实体瘤TCR平台和生产基地,金额未公开</blockquote>
BioNTech SE is buying a cell therapy R&D platform plus a manufacturing site from Gilead Science Inc'